Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-03-27 | Dr. Xuejun GuCTO, Exec. VP of Global Biologics Development Department & Executive Director | 148,13k | 0,00 | Derivative Exercise and Retained Stock | - | 1,32M | 12,63% |
| 2026-03-27 | Dr. Zhisheng ChenCEO & Executive Director | 16,72k | 0,00 | Derivative Exercise and Retained Stock | - | 46,04M | 0,04% |
| 2025-11-14 | Dr. Zhisheng ChenCEO & Executive Director | 3,00M | 499,24k | Derivative Exercise and Retained Stock | 0,17 | 38,97M | 8,34% |
| 2026-02-19 | BlackRock, Inc.Unternehmen | -18,21M | 0,00 | Other Disposition | - | 70,00M | -20,64% |
| 2026-02-11 | BlackRock, Inc.Unternehmen | -19,13M | 0,00 | Other Disposition | - | 69,99M | -21,46% |
| 2026-01-20 | Wuxi Biologics Holdings LimitedUnternehmen | -150,00M | 740,92M | Verkauf | 4,94 | 351,25M | -29,93% |
| 2026-01-05 | BlackRock, Inc.Unternehmen | -21,77M | 0,00 | Other Disposition | - | 65,78M | -24,86% |
| 2025-12-30 | Dr. Zhisheng ChenCEO & Executive Director | -18,90M | 0,00 | Other Disposition | - | 45,89M | -29,17% |
| 2025-12-17 | Dr. Zhisheng ChenCEO & Executive Director | -8,80M | 0,00 | Other Disposition | - | 45,89M | -16,09% |
| 2025-12-02 | Dr. Zhisheng ChenCEO & Executive Director | -3,16M | 12,68M | Verkauf | 4,01 | 45,89M | -6,44% |
| 2025-12-02 | Dr. Xuejun GuCTO, Exec. VP of Global Biologics Development Department & Executive Director | -41,64k | 168,26k | Verkauf | 4,04 | 1,30M | -3,11% |
| 2025-11-28 | BlackRock, Inc.Unternehmen | -6,83M | 0,00 | Other Disposition | - | 65,31M | -9,46% |
| 2025-11-27 | Dr. Zhisheng ChenCEO & Executive Director | -3,13M | 12,80M | Verkauf | 4,09 | 40,56M | -7,16% |
| 2025-11-28 | Dr. Zhisheng ChenCEO & Executive Director | 10,06M | 1,67M | Derivative Exercise and Retained Stock | 0,17 | 49,05M | 25,80% |
| 2025-11-28 | Dr. Zhisheng ChenCEO & Executive Director | -1,56M | 6,42M | Verkauf | 4,11 | 49,05M | -3,09% |
| 2025-11-25 | Dr. Zhisheng ChenCEO & Executive Director | 6,00M | 997,70k | Derivative Exercise and Retained Stock | 0,17 | 40,68M | 17,30% |
| 2025-11-26 | Dr. Zhisheng ChenCEO & Executive Director | 3,00M | 498,84k | Derivative Exercise and Retained Stock | 0,17 | 43,68M | 7,37% |
| 2025-11-21 | Dr. Xuejun GuCTO, Exec. VP of Global Biologics Development Department & Executive Director | 46,87k | 0,00 | Derivative Exercise and Retained Stock | - | 1,34M | 3,63% |
| 2025-11-20 | Dr. Zhisheng ChenCEO & Executive Director | -1,56M | 6,40M | Verkauf | 4,09 | 35,46M | -4,22% |
| 2025-11-21 | Dr. Zhisheng ChenCEO & Executive Director | -781,89k | 3,19M | Verkauf | 4,08 | 34,68M | -2,20% |
| 2025-11-19 | Dr. Zhisheng ChenCEO & Executive Director | 1,50M | 249,10k | Derivative Exercise and Retained Stock | 0,17 | 37,03M | 4,22% |
| 2025-11-18 | Dr. Zhisheng ChenCEO & Executive Director | 3,00M | 498,47k | Derivative Exercise and Retained Stock | 0,17 | 35,53M | 9,22% |
| 2025-11-18 | Dr. Zhisheng ChenCEO & Executive Director | -1,56M | 6,80M | Verkauf | 4,36 | 35,53M | -4,20% |
| 2025-11-17 | Dr. Zhisheng ChenCEO & Executive Director | -4,88M | 21,57M | Verkauf | 4,36 - 4,43 | 34,09M | -12,52% |
| 2025-11-13 | Dr. Zhisheng ChenCEO & Executive Director | 8,50M | 1,41M | Derivative Exercise and Retained Stock | 0,17 | 31,37M | 37,17% |
| 2025-11-13 | Dr. Zhisheng ChenCEO & Executive Director | -2,34M | 10,00M | Verkauf | 4,27 | 31,37M | -6,94% |
| 2025-11-14 | Dr. Zhisheng ChenCEO & Executive Director | -3,90M | 16,72M | Verkauf | 4,29 | 35,97M | -9,78% |
| 2025-11-12 | Dr. Zhisheng ChenCEO & Executive Director | 5,89M | 980,97k | Derivative Exercise and Retained Stock | 0,17 | 33,71M | 21,19% |
| 2025-11-12 | Dr. Zhisheng ChenCEO & Executive Director | -2,08M | 8,88M | Derivative Exercise and Sale | 0,17 - 4,40 | 33,71M | - |
| 2025-11-12 | Dr. Xuejun GuCTO, Exec. VP of Global Biologics Development Department & Executive Director | 2,58k | 0,00 | Derivative Exercise and Retained Stock | - | 1,29M | 0,20% |
| 2025-11-11 | Dr. Zhisheng ChenCEO & Executive Director | 2,68M | 446,25k | Derivative Exercise and Retained Stock | 0,17 | 27,81M | 10,67% |
| 2025-11-11 | Dr. Zhisheng ChenCEO & Executive Director | -1,82M | 7,62M | Derivative Exercise and Sale | 0,17 - 4,36 | 27,81M | - |
| 2025-11-10 | Dr. Zhisheng ChenCEO & Executive Director | 885,24k | 147,28k | Derivative Exercise and Retained Stock | 0,17 | 25,13M | 3,65% |
| 2025-11-10 | Dr. Zhisheng ChenCEO & Executive Director | -3,11M | 13,35M | Derivative Exercise and Sale | 0,17 - 4,45 | 25,13M | - |
| 2025-11-06 | Dr. Zhisheng ChenCEO & Executive Director | 9,50M | 1,58M | Derivative Exercise and Retained Stock | 0,17 | 24,25M | 64,42% |
| 2025-11-03 | Dr. Zhisheng ChenCEO & Executive Director | -996,00k | 0,00 | Other Disposition | - | 14,75M | -6,33% |
| 2025-10-09 | BlackRock, Inc.Unternehmen | -10,40M | 0,00 | Other Disposition | - | 64,13M | -13,96% |
| 2025-10-07 | BlackRock, Inc.Unternehmen | -36,77M | 0,00 | Other Disposition | - | 64,13M | -36,44% |
| 2025-10-01 | BlackRock, Inc.Unternehmen | -8,48M | 0,00 | Other Disposition | - | 64,13M | -11,68% |
| 2025-09-08 | Dr. Zhisheng ChenCEO & Executive Director | 6,00M | 995,80k | Derivative Exercise and Retained Stock | 0,17 | 29,75M | 25,27% |
| 2025-09-10 | Dr. Zhisheng ChenCEO & Executive Director | -6,00M | 29,42M | Verkauf | 4,90 | 14,75M | -28,92% |
| 2025-09-05 | Dr. Zhisheng ChenCEO & Executive Director | 9,00M | 1,49M | Derivative Exercise and Retained Stock | 0,17 | 23,75M | 61,03% |
| 2025-09-09 | Dr. Zhisheng ChenCEO & Executive Director | -9,00M | 42,48M | Verkauf | 4,72 | 20,75M | -30,25% |
| 2025-08-21 | BlackRock, Inc.Unternehmen | -4,32M | 0,00 | Other Disposition | - | 64,09M | -6,32% |
| 2025-08-14 | BlackRock, Inc.Unternehmen | -14,54M | 0,00 | Other Disposition | - | 72,48M | -16,71% |
| 2025-07-11 | BlackRock, Inc.Unternehmen | -6,67M | 0,00 | Other Disposition | - | 62,77M | -9,61% |
| 2025-07-09 | BlackRock, Inc.Unternehmen | -6,41M | 0,00 | Other Disposition | - | 62,77M | -9,27% |
| 2025-07-04 | BlackRock, Inc.Unternehmen | -14,22M | 0,00 | Other Disposition | - | 62,36M | -18,57% |
| 2025-06-24 | BlackRock, Inc.Unternehmen | -9,23M | 0,00 | Other Disposition | - | 61,30M | -13,09% |
| 2025-06-18 | Wuxi Biologics Holdings LimitedUnternehmen | -82,94M | 281,05M | Verkauf | 3,39 | 501,25M | -14,20% |
| 2025-06-17 | BlackRock, Inc.Unternehmen | -22,76M | 0,00 | Other Disposition | - | 61,41M | -27,04% |
| 2025-06-16 | Dr. Zhisheng ChenCEO & Executive Director | 189,04k | 0,00 | Derivative Exercise and Retained Stock | - | 14,64M | 1,31% |
| 2025-06-10 | Dr. Zhisheng ChenCEO & Executive Director | 264,87k | 0,00 | Derivative Exercise and Retained Stock | - | 14,45M | 1,87% |
| 2025-06-10 | Dr. Xuejun GuCTO, Exec. VP of Global Biologics Development Department & Executive Director | 29,68k | 0,00 | Derivative Exercise and Retained Stock | - | 1,28M | 2,38% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
